This is a limited company view. Sign up for a Free Trial to see everything.

Salient is developing CASAD™, a proprietary composition proven to adsorb a range of toxins and inflammatory proteins.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Houston

Founded

2007

Employees

1

Stage

Late

Total funding

$2M

Last funding

8 years ago

Acquisitions

0

Growth score

-1

Mindshare score

0

Scoring

Deals

$2.0M Venture

The Texas Emerging Technology Fund

Jan 29, 2010

Employee Growth

Use Salient Pharmaceuticals's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Salient Pharmaceuticals's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes